Sofosbuvir
Sofosbuvir is a small molecule antiviral prodrug, metabolized to an active uridine analog that potently inhibits the HCV NS5B RNA-dependent RNA polymerase. It is a key research tool for studying HCV replication mechanisms and evaluating antiviral efficacy in both cellular and animal models of hepatitis C infection.
Product Specifications
CAS Number
1190307-88-0
Product Name Alternative
Sofosbuvir, PSI 7977, PSI7977, PSI-7977, Inhibitor, HCV Protease, HCV, Hepatitis C virus, HCVProtease, GS7977, GS-7977, GS 7977, inhibit
Field of Research
Infectious Disease & Virology, Pharmacology & Drug Discovery, Protein Biochemistry
Purity
99.77% (May vary between batches)
Solubility
Ethanol:93 mg/mL (175.65 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:1 mg/mL (1.89 mM) ; DMSO:250 mg/mL (472.19 mM) ; H2O:9 mg/mL (17 mM)
Smiles
CC (C) OC (=O) [C@H] (C) NP (=O) (OC[C@H]1O[C@@H] (n2ccc (=O) [nH]c2=O) [C@] (C) (F) [C@@H]1O) Oc1ccccc1
Molecular Formula
C22H29FN3O9P
Molecular Weight
529.45
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Recombinant Pantoea ananas Geranylgeranyl pyrophosphate synthase (crtE)
Recombinant Pantoea ananas Geranylgeranyl pyrophosphate synthase (crtE)
Recombinant Pantoea ananas Geranylgeranyl pyrophosphate synthase (crtE)
Recombinant Pantoea ananas Geranylgeranyl pyrophosphate synthase (crtE)
Recombinant Pantoea ananas Geranylgeranyl pyrophosphate synthase (crtE)